drugset / Trial / NCT00828971
A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess if a therapy with intravenous and oral moxifloxacin is as effective as a therapy with intravenous and oral amoxicilline/clavulanate in the treatment of complicated skin and skin structure infection.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-09
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 875 mg | Intravenous |
| Subject | Moxifloxacin | Small molecule | 400 mg | Intravenous |
| Comparator | clavulanic acid | Small molecule | 125 mg | Intravenous |